Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy

References

• Parashar P, Rathor M, Dwivedi M, et al. Hyaluronic acid decorated naringenin nanoparticles: appraisal of chemopreventive and curative potential for lung cancer. Pharmaceutics. 2018;10(1):33.
   PubMed Web of Science ®Google Scholar
• Mandal B, Mittal NK, Balabathula P, et al. Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Sci. 2016;81:162–171.
   PubMed Web of Science ®Google Scholar
• Cheng W, Liang C, Xu L, et al. TPGS‐functionalized polydopamine‐modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance. Small. 2017;13(29):1700623.
   Web of Science ®Google Scholar
• Masood A, Kancha RK, Subramanian J. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: focus on afatinib. Semin Oncol. 2019;46(3):271–283.
   PubMed Web of Science ®Google Scholar
• Srinivas NS, Verma R, Kulyadi GP, et al. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomedicine. 2017;12:15–28.
   PubMed Web of Science ®Google Scholar
• Ni XL, Chen LX, Zhang H, et al. In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer. Drug Deliv. 2017;24(1):1501–1512.
   PubMed Web of Science ®Google Scholar
• Said-Elbahr R, Nasr M, Alhnan MA, et al. Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer. Eur J Pharm Biopharm. 2016;103:1–12.
   PubMed Web of Science ®Google Scholar
• Rosière R, Amighi K, Wauthoz N. Nanomedicine-based inhalation treatments for lung cancer. In: Prashant Kesharwani, editor. Nanotechnology-based targeted drug delivery systems for lung cancer.Elsevier Science; 2019. p. 249–268.
   Google Scholar
• El-Sherbiny IM, Smyth HD. Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres. Int J Pharm. 2010;395(1–2):132–141.
   PubMedGoogle Scholar
• Xu C, Wang Y, Guo Z, et al. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. J Control Release. 2019;295:153–163.
   PubMed Web of Science ®Google Scholar
• Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288–303.
   PubMed Web of Science ®Google Scholar
• Meenach SA, Vogt FG, Anderson KW, et al. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Int J Nanomedicine. 2013;8:275–293.
   PubMed Web of Science ®Google Scholar
• Pawar S, Vavia P. Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin. J Drug Target. 2016;24(1):68–79.
   PubMed Web of Science ®Google Scholar
• Aşık E, Aslan TN, Volkan M, et al. 2-Amino-2-deoxy-glucose conjugated cobalt ferrite magnetic nanoparticle (2DG-MNP) as a targeting agent for breast cancer cells. Environ Toxicol Pharmacol. 2016;41:272–278.
   PubMed Web of Science ®Google Scholar
• Wan X, Liu C, Lin Y, et al. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer. Drug Deliv. 2019;26(1):470–480.
   PubMed Web of Science ®Google Scholar
• Fang X, Xu Y, Wang S, et al. Pluronic F68-linoleic acid nano-spheres mediated delivery of gambogic acid for cancer therapy. AAPS PharmSciTech. 2017;18(1):147–155.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhao J, Lin X, et al. Design, synthesis and evaluation of dual-modality glyco-nanoparticles for tumor imaging. Molecules. 2013;18(6):6425–6438.
   PubMed Web of Science ®Google Scholar
• Zhong Q. Co-spray dried mannitol/poly(amidoamine)-doxorubicin dry-powder inhaler formulations for lung adenocarcinoma: morphology, in vitro evaluation, and aerodynamic performance. AAPS PharmSciTech. 2018;19(2):531–540.
   PubMed Web of Science ®Google Scholar
• Otroj M, Taymouri S, Varshosaz J, et al. Preparation and characterization of dry powder containing sunitinib loaded PHBV nanoparticles for enhanced pulmonary delivery. J Drug Deliv Sci Technol. 2020;56:101570.
   Web of Science ®Google Scholar
• Tan ME, He CH, Jiang W, et al. Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia-reperfusion injury in rats. Int J Nanomedicine. 2017;12:3253–3265.
   PubMed Web of Science ®Google Scholar
• Ganesan P, Narayanasamy D. Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain Chem Pharm. 2017;6:37–56.
   Web of Science ®Google Scholar
• Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech. 2009;10(1):211–219.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Taymouri S, Jahanian-Najafabadi A, et al. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study. IET Nanobiotechnol. 2018;12(6):795–806.
   PubMed Web of Science ®Google Scholar
• Emami J, Yousefian H, Sadeghi H. Targeted nanostructured lipid carrier for brain delivery of artemisinin: design, preparation, characterization, optimization and cell toxicity. J Pharm Pharm Sci. 2018;21(1s):225s–241s.
   PubMedGoogle Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Kathuria H, et al. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm. 2014;87(1):114–124.
   PubMed Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Biopharm. 2009;37(3–4):508–513.
   Google Scholar
• Tan SW, Billa N. Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles. AAPS PharmSciTech. 2014;15(2):287–295.
   PubMed Web of Science ®Google Scholar
• Aboud HM, Ali AA, El Menshawe SF, et al. Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery. AAPS PharmSciTech. 2016;17(6):1353–1365.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S, Khare P, et al. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 2010;17(6):443–451.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61(1–2):77–86.
   PubMed Web of Science ®Google Scholar
• Jain A, Kesharwani P, Garg NK, et al. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids Surf B Biointerfaces. 2015;134:47–58.
   PubMed Web of Science ®Google Scholar
• Heiati H, Phillips NC, Tawashi R. Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharm Res. 1996;13(9):1406–1410.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces. 2011;88(1):483–489.
   PubMed Web of Science ®Google Scholar
• Antoniou J, Liu F, Majeed H, et al. Physicochemical and morphological properties of size-controlled chitosan–tripolyphosphate nanoparticles. Colloids Surf A Physicochem Eng Asp. 2015;465:137–146.
   Web of Science ®Google Scholar
• Hajavi J, Sankian M, Varasteh AR, et al. Synthesis strategies for optimizing sizes of PLGA nanoparticles containing recombinant Chenopodium album (rChe a 3) allergen. Int J Polym Mater. 2017;66(12):603–608.
   Web of Science ®Google Scholar
• Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res Part B Appl Biomater. 2008;86(1):105–112.
   PubMedGoogle Scholar
• Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J Microencapsul. 1999;16(2):205–213.
   PubMed Web of Science ®Google Scholar
• Riley T, Govender T, Stolnik S, et al. Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles. Colloids Surf B Biointerfaces. 1999;16(1–4):147–159.
   Web of Science ®Google Scholar
• Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm. 2002;243(1–2):135–146.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–195.
   PubMed Web of Science ®Google Scholar
• Taymouri S, Varshosaz J, Hassanzadeh F, et al. Optimisation of processing variables effective on self-assembly of folate targeted Synpronic-based micelles for docetaxel delivery in melanoma cells. IET Nanobiotechnol. 2015;9(5):306–313.
   PubMed Web of Science ®Google Scholar
• Yang X, Trinh HM, Agrahari V, et al. Nanoparticle-based topical ophthalmic gel formulation for sustained release of hydrocortisone butyrate. AAPS PharmSciTech. 2016;17(2):294–306.
   PubMed Web of Science ®Google Scholar
• McCarron PA, Woolfson AD, Keating SM. Sustained release of 5-fluorouracil from polymeric nanoparticles. J Pharm Pharmacol. 2000;52(12):1451–1459.
   PubMed Web of Science ®Google Scholar
• Tavakoli N, Taymouri S, Saeidi A, et al. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis. Pharm Dev Technol. 2019;24(7):891–901.
   PubMed Web of Science ®Google Scholar
• Huang ZR, Hua SC, Yang YL, et al. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin. 2008;29(9):1094–1102.
   PubMed Web of Science ®Google Scholar
• Lee AL, Venkataraman S, Sirat SB, et al. The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs. Biomaterials. 2012;33(6):1921–1928.
   PubMed Web of Science ®Google Scholar
• Moghaddam PH, Ramezani V, Esfandi E, et al. Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin. Powder Technol. 2013;239:478–483.
   Web of Science ®Google Scholar
• Ezzati Nazhad Dolatabadi J, Hamishehkar H, Valizadeh H. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Dev Ind Pharm. 2015;41(9):1431–1437.
   PubMed Web of Science ®Google Scholar
• Grenha A, Remuñán-López C, Carvalho EL, et al. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm. 2008;69(1):83–93.
   Google Scholar
• Sinsuebpol C, Chatchawalsaisin J, Kulvanich P. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Drug Des Devel Ther. 2013;7:861.
   Google Scholar